AMPD3, OMIM*102772, AMP Deaminase Deficiency

Clinical trial pipeline · Data from ClinicalTrials.gov

See which AMPD3, OMIM*102772, AMP Deaminase Deficiency trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingNot Applicable

NCT06092346

A Natural History Study Seeks to Understand the Clinical, Genomic, Pharmacological, Laboratory, and Dietary Determinates…

Background: Pyrimidine and purine metabolism disorders (DPPMs) affect how the body metabolizes chemicals called pyrimidines and purines. DPPMs can cause dysfun…

United States999 participantsStarted 2023-12-19

AMPD3, OMIM*102772, AMP Deaminase Deficiency

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

A Natural History Study Seeks to Understand the Clinical, Genomic, Pharmacological, Laboratory, and Dietary Determinates…

All recent trials (1 shown)

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

A Natural History Study Seeks to Understand the Clinical, Genomic, Pharmacological, Laboratory, and Dietary Determinates…

All recent trials (1 shown)